SANDIMMUN NEORAL 50mg capsule me medication leaflet

L04AD01 • cyclosporine • Antineoplastic and immunomodulating agents | Immunosuppressants | Calcineurin inhibitors

Cyclosporine is an immunosuppressant used to prevent organ rejection after transplantation and to treat autoimmune conditions such as rheumatoid arthritis or severe psoriasis. It works by inhibiting T-lymphocyte activity, reducing the immune response.

The medication is administered orally or intravenously, as directed by a doctor. It is important for patients to undergo regular check-ups to monitor kidney function and blood cyclosporine levels.

Patients should be aware of potential side effects, such as high blood pressure, kidney dysfunction, or infections. It is important to inform the doctor of any unusual symptoms.

Common side effects include high blood pressure, kidney dysfunction, tremors, and hypertrichosis. In rare cases, severe reactions such as liver toxicity or serious infections may occur. Patients should be informed of these risks before starting treatment.

General data about SANDIMMUN NEORAL 50mg

Substance: cyclosporine

Date of last drug list: 01-06-2025

Commercial code: W70607001

Concentration: 50mg

Pharmaceutical form: capsule me

Quantity: 50

Product type: original

Price: 165.06 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: NOVARTIS PHARMA GMBH - GERMANIA

Holder: NOVARTIS EUROPHARM LIMITED - IRLANDA

Number: 6024/2013/01

Shelf life: 2 years

Pharmaceutical forms available for cyclosporine

capsules

capsule me

perfusive solution concentrate

ophthalmic drops emulsion

oral solution

Concentrations available for cyclosporine

165.06 RON

0.00 RON

SANDIMMUN NEORAL 50mg capsule me medication leaflet

General data about SANDIMMUN NEORAL 50mg

Marketing authorisation

Pharmaceutical forms available for cyclosporine

Concentrations available for cyclosporine

Other substances similar to cyclosporine

Compensation lists for SANDIMMUN NEORAL 50mg EUROPHARM

G10 (C1) - Leukemias, lymphomas and spinal cord aplasia, tumors

G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis

G25 (C1) - Chronic renal failure

G27 (C1) - Pemphigus

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

NHP 9.1 (C2) - Spinal cord transplant

NHP 9.2 (C2) - Heart transplant

NHP 9.3 (C2) - Liver Transplant

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

NHP 9.6 (C2) - Lung transplant

NHP 9.7 (C2) - Outpatient treatment of transplant patients